Industry News

CBN is revolutionizing the sleep aid market, gaining 0.86% quarterly to reach nearly $1 billion in U.S. sales, with projections to hit $5 billion by 2030, driven by its promising benefits and growing demand for natural solutions.

Multi-cannabinoid edibles with CBD, CBN, CBG, CBC, and THCv are overtaking THC-only products, hitting $2.5 billion by 2024, driven by consumer demand and scientific insights.

In recent years, the interest in cannabinoids—compounds found in the cannabis plant—has surged, not just among researchers but also within the general populace seeking alternative therapies for various health issues.